Keeping at least one meter apart and wearing face masks and eye protection are the best ways to cut the risk of COVID-19 infection, according to the largest review to date of studies on coronavirus disease transmission.

COVID-19 is many things. It is creating an economic impact like we have never seen before, it’s a lesson in basic hygiene, a test in societal patience, an enormous challenge, and a rare opportunity. It also demonstrates why many have chosen the pharmaceutical profession.

Gilead Sciences has been overwhelmed with requests for remdesivir to treat cases of COVID-19, the disease caused by the novel coronavirus.

A global coalition set up to fight emerging epidemics will give $19 million to drugmaker Johnson & Johnson’s vaccine unit and Oxford University experts to work on immunizations against three major diseases.

A global coalition set up during 2017 to fight epidemics has struck a $25 million deal with two U.S. biotech companies to accelerate work on a vaccine against the brain-damaging Nipah virus that has killed 12 people in India.

A private British company is developing a vaccine that would be the first in the world to fight all types of flu.

Human antibodies made in genetically engineered cows have proved safe in an early-stage clinical trial.

Anyone who goes down with flu in Europe this winter could be asked to enroll in a randomized clinical trial in which they will either be given a drug, which […]

The United States and Saudi Arabia are discussing the possibility of readying a vaccine for Middle East Respiratory Syndrome (MERS) before the next outbreak of the disease, the head of […]

Global health experts called on Wednesday for the creation of a $2 billion vaccine development fund to feed a pipeline of potential new shots against priority killer diseases like Ebola, […]